Surgery Partners SGRY
Surgery Partners reported a net loss of $21.1 million for the three months ended Sep 30, 2026.
Surgery Partners (SGRY) filed a 10-Q with the SEC on Nov 9, 2026, 5:14 pm ET. Source: the filing on SEC EDGAR.
- Form
- 10-Q
- Filed
- Importance
- Major
- Accession
- 0001638833-26-000090
- Revenue was $815.3 million for the three months ended Sep 30, 2026.
- Net loss was $21.1 million for the three months ended Sep 30, 2026.
- Diluted EPS was -$0.16 for the three months ended Sep 30, 2026.
- Cash and equivalents were $354.5 million as of Sep 30, 2026.
Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.
What changed since last quarter
1 new risk factor · 1 new legal mention
Compared with the 10-Q for the period ended Jun 30, 2026.
| This filing | Previous | Change vs prior 10-Q | |
|---|---|---|---|
| Operating income and margin | $85.6M | $102.1M | −16% |
| Net income | −$21.1M | −$15M | −41% |
| Operating cash flow | $103.5M | $59.3M | +75% |
| Cash | $354.5M | $216.7M | +64% |
New risk factors (1)
- We may not complete the Merger within the anticipated timeframe, or at all, which could have a material adverse impact on our business, financial condition or results of operations, as well as negatively impact the per share price of our common stock. +26 more paragraphs
New legal mentions (1)
- Completion of the Merger is subject to the satisfaction or waiver of certain customary closing conditions, including the adoption of the Amended Merger Agreement by the Company's stockholders and receipt of required regulatory approvals under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. +3 more paragraphs